305 related articles for article (PubMed ID: 16715090)
1. Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells.
Siragam V; Crow AR; Brinc D; Song S; Freedman J; Lazarus AH
Nat Med; 2006 Jun; 12(6):688-92. PubMed ID: 16715090
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.
Crow AR; Song S; Siragam V; Lazarus AH
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):710-3. PubMed ID: 16933274
[TBL] [Abstract][Full Text] [Related]
3. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
Siragam V; Brinc D; Crow AR; Song S; Freedman J; Lazarus AH
J Clin Invest; 2005 Jan; 115(1):155-60. PubMed ID: 15630455
[TBL] [Abstract][Full Text] [Related]
4. Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype.
Pierangeli SS; Espinola R; Liu X; Harris EN; Salmon JE
Arthritis Rheum; 2001 Apr; 44(4):876-83. PubMed ID: 11315927
[TBL] [Abstract][Full Text] [Related]
5. Protective mechanisms of IVIG.
Clynes R
Curr Opin Immunol; 2007 Dec; 19(6):646-51. PubMed ID: 18032008
[No Abstract] [Full Text] [Related]
6. Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells.
Bazin R; Lemieux R; Tremblay T; St-Amour I
Br J Haematol; 2004 Oct; 127(1):90-6. PubMed ID: 15384982
[TBL] [Abstract][Full Text] [Related]
7. Chemically dimerized intravenous immunoglobulin has potent ameliorating activity in a mouse immune thrombocytopenic purpura model.
Machino Y; Suzuki E; Higurashi S; Ohta H; Suzuki M; Kohroki J; Masuho Y
Biochem Biophys Res Commun; 2012 Feb; 418(4):748-53. PubMed ID: 22306012
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura.
Jin F; Balthasar JP
Hum Immunol; 2005 Apr; 66(4):403-10. PubMed ID: 15866704
[TBL] [Abstract][Full Text] [Related]
9. Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin.
Leontyev D; Katsman Y; Ma XZ; Miescher S; Käsermann F; Branch DR
Transfusion; 2012 Aug; 52(8):1799-805. PubMed ID: 22257295
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice.
Huang HS; Sun DS; Lien TS; Chang HH
Blood; 2010 Dec; 116(23):5002-9. PubMed ID: 20699442
[TBL] [Abstract][Full Text] [Related]
11. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?
Crow AR; Lazarus AH
Transfus Med Rev; 2008 Apr; 22(2):103-16. PubMed ID: 18353251
[TBL] [Abstract][Full Text] [Related]
12. Adoptive-transfer effects of intravenous immunoglobulin in autoimmunity.
Lazarus AH
J Clin Immunol; 2010 May; 30 Suppl 1():S20-3. PubMed ID: 20401687
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of IVIG action in immune thrombocytopenic purpura.
Hansen RJ; Balthasar JP
Clin Lab; 2004; 50(3-4):133-40. PubMed ID: 15074465
[TBL] [Abstract][Full Text] [Related]
14. CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption.
Crow AR; Amash A; Lazarus AH
Transfusion; 2015 Jun; 55(6 Pt 2):1492-500. PubMed ID: 25496771
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia.
Tremblay T; Paré I; Bazin R
Transfusion; 2013 Feb; 53(2):261-9. PubMed ID: 22670706
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of action of intravenous immunoglobulins.
Baerenwaldt A; Biburger M; Nimmerjahn F
Expert Rev Clin Immunol; 2010 May; 6(3):425-34. PubMed ID: 20441428
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg.
Song S; Crow AR; Siragam V; Freedman J; Lazarus AH
Blood; 2005 Feb; 105(4):1546-8. PubMed ID: 15479722
[TBL] [Abstract][Full Text] [Related]
18. FcgammaRIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin.
Park-Min KH; Serbina NV; Yang W; Ma X; Krystal G; Neel BG; Nutt SL; Hu X; Ivashkiv LB
Immunity; 2007 Jan; 26(1):67-78. PubMed ID: 17239631
[TBL] [Abstract][Full Text] [Related]
19. A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?
Crow AR; Song S; Semple JW; Freedman J; Lazarus AH
Blood; 2007 Jan; 109(1):155-8. PubMed ID: 16954498
[TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid dendritic cells, interferon signaling, and FcγR contribute to pathogenesis and therapeutic response in childhood immune thrombocytopenia.
Sehgal K; Guo X; Koduru S; Shah A; Lin A; Yan X; Dhodapkar KM
Sci Transl Med; 2013 Jul; 5(193):193ra89. PubMed ID: 23843450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
